Buscar resultados de ensayos clínicos
Oligodendroglioma - 253 Studies Found
Estado | Estudiar |
Completed |
Nombre del estudio: Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Recurrent Malignant Glioma Condición:
Intervenciones: |
Suspended |
Nombre del estudio: Viral Therapy in Treating Patients With Recurrent Glioblastoma Multiforme Condición:
Intervenciones: |
Active, not recruiting |
Nombre del estudio: Study of a Retroviral Replicating Vector Given Intravenously to Patients Undergoing Surgery for Recurrent Brain Tumor Condición:
|
Active, not recruiting |
Nombre del estudio: Study of a Retroviral Replicating Vector to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor Condición:
|
Terminated |
Nombre del estudio: Phase 2 Trial Using Talampanel in Patients With Recurrent High Grade Gliomas Condición:
|
Completed |
Nombre del estudio: Research of Molecular and Metabolic Markers in Oligodendrogliomas Comparatively to Other Brain Tumours Condición: Oligodendrogliomas Fecha: 2005-09-13 |
Recruiting |
Nombre del estudio: Safety and Efficacy of PD0332991 (Palbociclib), a Cyclin-dependent Kinase 4 and 6 Inhibitor, in Patients With Oligodendroglioma or Recurrent Oligoastrocytoma Anaplastic With the Activity of the Protein RB Preserved Condición:
Fecha: 2015-08-18 Intervenciones: Drug: Palbociclib Palbociclib will be administered orally at a dose of 125 mg/day, until disease progres |
Completed |
Nombre del estudio: Temozolomide in Relapsed or Advanced Anaplastic Oligodendroglioma and Oligoastrocytoma: Single-arm, Phase II Trial Condición:
Fecha: 2013-04-29 Intervenciones: Drug: Temozolomide Temozolomide 200 mg/m2/d in a fasting state for 5 consecutive days (1,000 mg/m2 per 2 |
Completed |
Nombre del estudio: Temozolomide in Patients With Newly Diagnosed Anaplastic Oligodendroglioma and Mixed Oligoastrocytoma Condición:
Fecha: 2006-08-08 Intervenciones: Drug: Temozolomide p.o.(by mouth), 150 mg/m2/d x days 1-7 |
Terminated |
Nombre del estudio: Phase II Study of Irinotecan HCI for Recurrent Anaplastic Astrocytomas, Mixed Malignant Gliomas, and Oligodendrogliomas Condición:
|